Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Alzheimer's Disease

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    June 2020
  1. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet. 2020;395:1988-1997.
    PubMed     Abstract available


  2. HEAD E, Ances B
    Biomarkers in Down syndrome can help us understand Alzheimer's disease.
    Lancet. 2020;395:1951-1953.
    PubMed    


    February 2020
  3. SEN A, Jette N, Husain M, Sander JW, et al
    Epilepsy in older people.
    Lancet. 2020;395:735-748.
    PubMed     Abstract available


  4. WATTS G
    Giovanna Mallucci: redefining neurodegeneration.
    Lancet. 2020;395:486.
    PubMed    


    September 2019
  5. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    PubMed    


    August 2019
  6. BAKHTA K, Cecillon E, Lacombe E, Lamy M, et al
    Alzheimer's disease and neurodegenerative diseases in France.
    Lancet. 2019;394:466-467.
    PubMed    


    April 2019
  7. BARNETT R
    Alzheimer's disease.
    Lancet. 2019;393:1589.
    PubMed    


    January 2019
  8. SCHOTT JM, Aisen PS, Cummings JL, Howard RJ, et al
    Unsuccessful trials of therapies for Alzheimer's disease.
    Lancet. 2019;393:29.
    PubMed    


  9. ANDERSON RM, Hadjichrysanthou C, Evans S, McRae-McKee K, et al
    Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
    Lancet. 2019;393:29-30.
    PubMed    


    June 2018
  10. BURKI T
    Alzheimer's disease research: the future of BACE inhibitors.
    Lancet. 2018;391:2486.
    PubMed    


    February 2018
  11. WATTS G
    Prospects for dementia research.
    Lancet. 2018;391:416.
    PubMed    


    November 2017
  12. ANDERSON RM, Hadjichrysanthou C, Evans S, Wong MM, et al
    Why do so many clinical trials of therapies for Alzheimer's disease fail?
    Lancet. 2017;390:2327-2329.
    PubMed    


    December 2016
  13. THE LANCET
    Alzheimer's disease: expedition into the unknown.
    Lancet. 2016;388:2713.
    PubMed    


    November 2016
  14. GAUTHIER S, Feldman HH, Schneider LS, Wilcock GK, et al
    Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)31275.
    PubMed     Abstract available


  15. RAFII MS
    Targeting tau protein in Alzheimer's disease.
    Lancet. 2016 Nov 15. pii: S0140-6736(16)32107.
    PubMed    


  16. SNYDER A
    Allen Roses.
    Lancet. 2016;388:2232.
    PubMed    


    August 2016
  17. SCHNEIDER LS
    Reduce vascular risk to prevent dementia?
    Lancet. 2016;388:738-40.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: